Novartis challenges Roche with MabThera biosimilar
January 11, 2011Research and Development Lonza MabThera, Novartis, Roche, Teva, biosimilar, rituximab
Novartis’ generics unit Sandoz has begun mid-stage trials of a biosimilar version of Roche’s blockbuster drug MabThera. The phase II …
FDA launches online transparency initiative
January 11, 2011Medical Communications, Research and Development, Sales and Marketing FDA, Joshua Sharfstein, transparency
The FDA has launched a new online resource to increase the transparency of its processes and help save companies time …
Dendreon will outsource first Provenge production in EU
January 11, 2011Manufacturing and Production Dendreon, Provenge, cancer vaccine, contract manufacturing, sipuleucel-T, vaccine manufacturing, vaccines
US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …
Sanofi boosts emerging markets leadership team
January 11, 2011Sales and Marketing Brazil, China, Heraldo Marchezini, Japan, Jeremy Moulding Russia, Patrick Aghanian, Sanofi-Aventis, Thomas Kelly, appointments, emerging markets, sales and marketing
Sanofi-Aventis has bolstered its emerging markets team with the appointment of four senior managers. They are Patrick Aghanian, Thomas Kelly, …
Doctors use GSK’s Pandemrix as seasonal flu vaccines fall short
January 10, 2011Sales and Marketing GSK, GlaxoSmithKline, Pandemrix, flu, h1n1, influenza, vaccines
Doctors may have to use last year’s stock of the H1N1 vaccine Pandemrix as the government admits there are some …
Sanofi’s Genzyme takeover bid focuses on Campath
January 10, 2011Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, biotech acquisition
Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …
More US recalls as bill seeks greater FDA powers
January 10, 2011Manufacturing and Production Centocor Ortho Biotech, Cumberland Pharmaceuticals, FDA, RiteDose Corp, Sandoz, Sigma-tau Pharmasource, Teva Pharmaceuticals, manufacturing compliance, recalls
Product recalls continue to make headlines in the pharmaceutical sector, with several new incidents either side of the New Year …
Dendreon eyes late 2011 European cancer vaccine filing
January 10, 2011Sales and Marketing Cancer, Denreon, Provenge, cancer vaccine, sipuleucel, vaccines
Dendreon Group is to seek marketing authorisation in Europe for the world’s first immunotherapy cancer vaccine in late 2011 or …
Cephalon’s Paul Harmon joins IPHA board
January 10, 2011Sales and Marketing Cephalon, IPHA, Paul Harmon, appointment, sales and marketing
Cephalon’s Paul Harmon has been elected to the prescription medicines division strategy board of Irish pharma association IPHA, a role …
Regulators fast-track Merck’s hepatitis C drug boceprevir
January 7, 2011Sales and Marketing Merck & Co, boceprevir, hepatitis C, telaprevir
Merck’s new oral hepatitis C drug boceprevir will receive fast track reviews from both the FDA and the EMA after …
Digital Pharma: Pfizer, J&J and Merck withdraw iPhone apps
January 7, 2011Medical Communications Android, Blackberry, Digital Pharma blog, Johnson & Johnson, Merck, Pfizer, apps, ipad, iphone
Big pharma companies have pulled a number of apps from the iTunes store, but it’s not a sign the industry …
Just:: to help three health charities
January 7, 2011Medical Communications charity, just health pr
Three healthcare charities are to receive help with communications free of charge from Just:: Health PR. The PR company is …
GSK signs £64m autoimmune antibody deal
January 7, 2011Research and Development GSK, GlaxoSmithKline, ImmuTune IMP731, Immutep, autoimmune diseases
GlaxoSmithKline has signed a worldwide licence agreement for a novel antibody designed to treat autoimmune diseases.The company will pay up …
Sanofi workers strike in France
January 7, 2011Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis, strikes, unions
Sanofi-Aventis workers have gone on strike in France as the company looks to cut jobs. Nine unions representing workers at …
Clare Panter joins Woolley Pau PR
January 7, 2011Medical Communications Clare Panter, Woolley Pau, appointment, medical communications
Clare Panter has joined Woolley Pau’s PR arm as a PR account executive. She is a keen writer and recently …
Study highlights Avastin heart failure risk
January 6, 2011Research and Development, Sales and Marketing Roche, avastin, bevacizumab, breast cancer
A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …
Biogen Idec appoints new head of R&D
January 6, 2011Research and Development, Sales and Marketing Biogen IDEC, Douglas Williams, Steven Holtzman, appointment, research and development, sales and marketing
Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …
Janssen’s Invega wins schizoaffective approval in Europe
January 6, 2011Sales and Marketing Invega, Janssen, paliperidone ER, schizoaffective disorder, schizophrenia
Janssen’s Invega has become the first drug to be licensed in Europe to treat schizoaffective disorder. European regulators approved Invega …
Leukaemia drug fast-tracked by NICE
January 6, 2011Sales and Marketing Bendamustine, Levact, NICE, Napp, chronic lymphocytic leukaemia, leukaemia
A treatment for patients with the most common form of leukaemia has been fast tracked by NICE because of strong …
Bayer submits new Xarelto indications for European approval
January 6, 2011Sales and Marketing Bayer, DVT, Xarelto, atrial fibrillation, deep vein thrombosis, pulmonary embolism, rivaroxaban, stroke prevention
Bayer is seeking European regulatory approval for a batch of new indications for its oral anticoagulant Xarelto. The company is …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
